Difference between revisions of "Example orders for Cetuximab (Erbitux) in colon cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "#Cetuximab_.28Erbitux.29" to "#Cetuximab_monotherapy") |
Warner-admin (talk | contribs) m (Text replacement - "/m2 " to "/m<sup>2</sup> ") |
||
Line 10: | Line 10: | ||
===Example regimen #1=== | ===Example regimen #1=== | ||
For cycle 1: | For cycle 1: | ||
− | *[[Cetuximab (Erbitux)]] 400 mg/ | + | *[[Cetuximab (Erbitux)]] 400 mg/m<sup>2</sup> IV over 120 minutes on day 1 |
**Use non-DEHP/paclitaxel tubing. | **Use non-DEHP/paclitaxel tubing. | ||
− | *[[Cetuximab (Erbitux)]] 250 mg/ | + | *[[Cetuximab (Erbitux)]] 250 mg/m<sup>2</sup> IV over 60 minutes on days 8, 15, 22 |
**Use non-DEHP/paclitaxel tubing. | **Use non-DEHP/paclitaxel tubing. | ||
Line 27: | Line 27: | ||
*Hold if ANC <1000 or platelets <100 and notify physician. | *Hold if ANC <1000 or platelets <100 and notify physician. | ||
For cycle 2 and later: | For cycle 2 and later: | ||
− | *[[Cetuximab (Erbitux)]] 250 mg/ | + | *[[Cetuximab (Erbitux)]] 250 mg/m<sup>2</sup> IV over 60 minutes on days 1, 8, 15, 22 |
**Use non-DEHP/paclitaxel tubing. | **Use non-DEHP/paclitaxel tubing. | ||
'''28-day cycles''' | '''28-day cycles''' |
Revision as of 14:13, 9 September 2017
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Cetuximab (Erbitux)
Original references may be found at Cetuximab (Erbitux)
Example regimen #1
For cycle 1:
- Cetuximab (Erbitux) 400 mg/m2 IV over 120 minutes on day 1
- Use non-DEHP/paclitaxel tubing.
- Cetuximab (Erbitux) 250 mg/m2 IV over 60 minutes on days 8, 15, 22
- Use non-DEHP/paclitaxel tubing.
28-day cycle
Supportive medications:
- Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to cetuximab
- Diphenhydramine (Benadryl) 50 mg IV 30 minutes prior to cetuximab
Hydration:
- 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Hold if ANC <1000 or platelets <100 and notify physician.
For cycle 2 and later:
- Cetuximab (Erbitux) 250 mg/m2 IV over 60 minutes on days 1, 8, 15, 22
- Use non-DEHP/paclitaxel tubing.
28-day cycles
Supportive medications:
- Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to cetuximab
- Diphenhydramine (Benadryl) 50 mg IV 30 minutes prior to cetuximab
Hydration:
- 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Hold if ANC <1000 or platelets <100 and notify physician.
Comments:
- My institution uses 28-day cycles for Cetuximab (Erbitux) regimens.